SK Bioscience
From Wikipedia, the free encyclopedia
 | |
Native name | 에스케이바이오사이언스 주식회사 |
|---|---|
| Company type | Public |
| KRX: 302440 | |
| Industry | Biotechnology |
| Founded | 2018; 8 years ago (2018) |
| Headquarters | Bundang District, Seongnam, Gyeonggi-do , South Korea |
| Products | Vaccine |
Number of employees | 1,126 (2024) |
| Parent | SK Chemicals |
| Website | www |
SK Bioscience (Korean: SK바이오사이언스) is a South Korean biotechnology company that produces vaccines and other products and is a subsidiary of SK Chemicals.
SK Chemicals was responsible for all research and development (R&D), production, and sales of chemically synthesized pharmaceuticals, biopharmaceuticals, natural medicines, blood products, and vaccines, but the blood products division was spun off into SK Plasma and the vaccine division into SK Bioscience in July 2018.[1]
In 2024, it acquired the German global pharmaceutical and biotechnology company Cloquet Group and IDT Biologica, a Contract manufacturing organization (CMO) specialized in pharmaceuticals.[2][3]
SK Bioscience and SK Biopharm are both part of the SK Group, but their governance structures are different: SK Biopharm is part of the SK Inc., while SK Bioscience is part of the SK Discovery Group.[4]
On 26 September, SK Bio Pharmaceutics stocks was down 1.71% after US President Donald Trump announced fresh tariffs on pharmaceutical products.[5]
Business
The headquarters is located in Bundang District, Seongnam in Gyeonggi-do. The first cell culture vaccine factory in South Korea is SK Bioscience's Andong vaccine factory. This factory was completed in December 2012 with a total investment of 200 billion won, including 160 billion won in facility investment and 40 billion won in research and development.[6]
References
- ↑ 국산 신약 1호 '선플라'…SK, 새 역사를 쓰다[약전약후]. news1. 19 May 2024.
- ↑ "SK바이오사이언스, 독일 백신 생산기업 3390억원에 인수". Korea Economic Daily. 27 June 2024.
- ↑ '인수·합병' 마친 바이오 기업들…"실적으로 입증 하겠다". Newsis. 7 October 2024.
- ↑ "SK바이오팜·SK바이오사이언스, 세계 최대 바이오 전시회서 '따로 또 같이' 사업 확장 모색". The Dong-A Ilbo. 4 June 2024.
- ↑ Jie, Nur Hikmah Md Ali,Lim Hui (25 September 2025). "Asian pharma stocks extend declines after Trump slaps 100% levies on branded drugs". CNBC. Retrieved 30 January 2026.
{{cite web}}: CS1 maint: multiple names: authors list (link) - ↑ 국내 첫 '세포배양' 백신 만드는 SK케미칼 안동공장. news1. 27 November 2013.
| Ownership | | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current subsidiaries |
| ||||||||||
| Sports | |||||||||||
| Companies | |||||||
|---|---|---|---|---|---|---|---|
| Government and regulatory bodies | |||||||
| Industry and professional bodies |
| ||||||
| Other | |||||||
